GLPG +24%/AH on phase-2 data in IPH: https://globenewswire.com/news-release/2017/08/09/1082725/0/en/GLPG1690-halts-disease-progression-in-IPF-patients-in-FLORA-Phase-2a-trial.html CC tomorrow 8am ET.